Pommerville P - Search Results

Year	Number of Results
1982	1
1996	1
1999	1
2000	1
2003	2
2004	1
2005	4
2006	7
2008	4
2009	4
2010	7
2011	4
2012	4
2013	4
2014	2
2015	1
2016	4
2017	1
2024	0

1

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.

2

GnRH antagonists in the treatment of advanced prostate cancer.

Pommerville PJ, de Boer JG. Pommerville PJ, et al. Can J Urol. 2010 Apr;17(2):5063-70. Can J Urol. 2010. PMID: 20398443 Review.

3

A surgical challenge: Idiopathic scrotal elephantiasis.

Brotherhood HL, Metcalfe M, Goldenberg L, Pommerville P, Bowman C, Naysmith D. Brotherhood HL, et al. Among authors: pommerville p. Can Urol Assoc J. 2014 Jul;8(7-8):E500-7. doi: 10.5489/cuaj.1739. Can Urol Assoc J. 2014. PMID: 25132898 Free PMC article.

4

From bedside to bed. Recovery of sexual function after prostate cancer.

Pommerville PJ. Pommerville PJ. Can Fam Physician. 2005 Jul;51(7):941-3, 948-50. Can Fam Physician. 2005. PMID: 16060168 Free PMC article. No abstract available.

5

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group. Andriole GL, et al. N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127. N Engl J Med. 2010. PMID: 20357281 Free article. Clinical Trial.

6

Erectile dysfunction: an overview.

Pommerville P. Pommerville P. Can J Urol. 2003 Feb;10 Suppl 1:2-6. Can J Urol. 2003. PMID: 12625843 Review.

7

Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.

Hoag N, Pommerville PJ, Kibsey PC, Cavers DJ, Eddy RJ. Hoag N, et al. Among authors: pommerville pj. Can J Urol. 2009 Apr;16(2):4589-91. Can J Urol. 2009. PMID: 19364433

8

Anticholinergics for overactive bladder: Temporal trends in prescription and treatment persistence.

Wallis CJ, Lundeen C, Golda N, Brotherhood H, Pommerville P, Carr L. Wallis CJ, et al. Among authors: pommerville p. Can Urol Assoc J. 2016 Aug;10(7-8):277-280. doi: 10.5489/cuaj.3526. Can Urol Assoc J. 2016. PMID: 27878051 Free PMC article.

9

Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*.

Herschorn S, Heesakkers J, Castro-Diaz D, Wang JT, Brodsky M, Guan Z; Disease Management Study Team. Herschorn S, et al. Curr Med Res Opin. 2008 Dec;24(12):3513-21. doi: 10.1185/03007990802537122. Curr Med Res Opin. 2008. PMID: 19032133 Clinical Trial.

10

Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes.

Ory J, Flannigan R, Lundeen C, Huang JG, Pommerville P, Goldenberg SL. Ory J, et al. Among authors: pommerville p. J Urol. 2016 Oct;196(4):1082-9. doi: 10.1016/j.juro.2016.04.069. Epub 2016 Apr 27. J Urol. 2016. PMID: 27131465 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year